Kinetics of purified protein derivative (PPD) proliferation reflects underlying suppressor mechanisms revealed by limiting dilution analysis (LDA) in patients with extrapulmonary tuberculosis (TB)

Mononuclear leucocytes from the blood (PBML) and effusion (EML) of patients undergoing pericardiocentesis were assayed for proliferative response to purified protein derivative of Mycobacterium tuberculosis (PPD). Of the 23 patients tested, 10 had culture‐positive tuberculous effusions, while 13 had non‐tuberculous aetiologies. Three different kinetic responses were identified: (i) accelerated responses (found in 70% of EML from patients with culture‐positive tuberculous effusions); (ii) ‘flat’ responses (found in 10% of EML from patients with culture‐positive tuberculous effusions); and (iii) normal kinetic responses. These differences in kinetic response may reflect underlying immune mechanisms important in the immunopathogenesis of TB. In order to address this possibility we performed LDA on a selection of patients with culture‐positive extrapulmonary TB: three patients with accelerated responses, two with normal responses, and one with a ‘flat’ response. The results confirm the previously reported accumulation of PPD‐specific responder cells in the effusion of patients with TB. Cell‐mediated suppressor mechanisms (as shown by ‘V’‐shaped LDA curves) were found in the blood of one patient and the effusion of another. In both cases ‘flat’ PPD‐proliferative responses were observed. However, the LDA data also suggested the presence of in vivo mechanisms limiting the clonal burst size. Thus it appears that immune responses in extrapulmonary TB are influenced by an array of inhibitory mechanisms, modulation of which may influence the outcome of infection.

[1]  R. Flavell,et al.  Regulation of the activity of the transcription factors AP-1 and NFAT during differentiation of precursor CD4+ T-cells into effector cells. , 1997, Biochemical Society transactions.

[2]  K. Shimokata [Commemorative lecture of receiving Imamura Memorial Prize. Analysis of cellular immunity against tuberculosis in man with special reference to tuberculous pleurisy and cytokines]. , 1996, Kekkaku : [Tuberculosis].

[3]  R. Miller,et al.  Regulatory interactions between virgin and memory CD4 T lymphocytes. , 1996, Cellular immunology.

[4]  B. Bloom,et al.  Immune response to recombinant mycobacterial proteins in patients with tuberculosis infection and disease. , 1996, The Journal of infectious diseases.

[5]  S. Latouf,et al.  Memory lymphocytes from tuberculous effusions: purified protein derivative (PPD) stimulates accelerated activation marker expression and cell cycle progression , 1996, Clinical and experimental immunology.

[6]  G. V. Lutsenko,et al.  Analysis of cellular interactions in limiting dilution cultures. , 1996, Journal of immunological methods.

[7]  R. Miller,et al.  Antagonistic interactions among T cell subsets of old mice revealed by limiting dilution analysis. , 1995, Journal of immunology.

[8]  R. Lechler,et al.  Anergic T cells as suppressor cells in vitro. , 1994, Science.

[9]  F. Erard,et al.  Non-cytotoxic, IL-4, IL-5, IL-10 producing CD8+ T cells: their activation and effector functions. , 1994, Current opinion in immunology.

[10]  D. Kemeny,et al.  Immune regulation: a new role for the CD8+ T cell. , 1994, Immunology today.

[11]  I. Orme The role of CD8+ T cells in immunity to tuberculosis infection. , 1993, Trends in microbiology.

[12]  J. Flynn,et al.  Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[13]  F. Lorgat,et al.  Cellular immunity in tuberculous pleural effusions: evidence of spontaneous lymphocyte proliferation and antigen‐specific accelerated responses to purified protein derivative (PPD) , 1992, Clinical and experimental immunology.

[14]  E. Shevach,et al.  IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function. , 1992, Journal of immunology.

[15]  J. Suttles,et al.  T cells bearing the CD44hi "memory" phenotype display characteristics of activated cells in G1 stage of cell cycle. , 1992, Cellular immunology.

[16]  F. Lorgat,et al.  Evidence for in vivo generation of cytotoxic T cells. PPD-stimulated lymphocytes from tuberculous pleural effusions demonstrate enhanced cytotoxicity with accelerated kinetics of induction. , 1992, The American review of respiratory disease.

[17]  H. Saka,et al.  Cytokine content in pleural effusion. Comparison between tuberculous and carcinomatous pleurisy. , 1991, Chest.

[18]  B. Balbi,et al.  Limited clonal heterogeneity of antigen-specific T cells localizing in the pleural space during mycobacterial infection , 1991, Infection and immunity.

[19]  S. Man,et al.  Limiting dilution analysis of human T cells: a useful clinical tool. , 1990, Immunology today.

[20]  P. Barnes,et al.  Compartmentalization of a CD4+ T lymphocyte subpopulation in tuberculous pleuritis. , 1989, Journal of immunology.

[21]  G. Mullin,et al.  Tuberculosis as a manifestation of the acquired immunodeficiency syndrome. , 1986, JAMA.

[22]  T. Maniatis,et al.  Tuberculosis as a manifestation of the acquired immunodeficiency syndrome (AIDS). , 1986, JAMA.

[23]  H. Fujiwara,et al.  Frequency of tuberculin-reactive T-lymphocytes in pleural fluid and blood from patients with tuberculous pleurisy. , 1986, Chest.

[24]  I Lefkovits,et al.  Limiting dilution analysis of the cells of immune system I. The clonal basis of the immune response. , 1984, Immunology today.

[25]  R. Miller Age-associated decline in precursor frequency for different T cell-mediated reactions, with preservation of helper or cytotoxic effect per precursor cell. , 1984, Journal of immunology.

[26]  Richard A. Miller Clonal endurance and clonal burst size: novel indices of helper T cell heterogeneity , 1984, European journal of immunology.

[27]  S. Grzybowski Tuberculosis. A look at the world situation. , 1983, Chest.

[28]  S. Benatar Tuberculosis in the 1980s, with particular reference to South Africa. , 1982, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[29]  H. von Boehmer,et al.  Suppression of T cell responses through competition for T cell growth factor (interleukin 2) , 1982, European journal of immunology.

[30]  Fazekas de St Groth The evaluation of limiting dilution assays. , 1982, Journal of immunological methods.

[31]  E. Engleman,et al.  Activation of human T lymphocyte subsets: helper and suppressor/cytotoxic T cells recognize and respond to distinct histocompatibility antigens. , 1981, Journal of immunology.

[32]  Ra Thompson,et al.  Limiting Dilution Analysis of Cells in the Immune System , 1980 .

[33]  I. Lefkovits Limiting Dilution Analysis , 1979 .